← Back to Search

N/A

Patients evaluated using flexible nasopharyngoscope prototype device for Oral Cancers

N/A

Waitlist Available

Led By Walter Lee, MD

Research Sponsored by Duke University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 15 minutes

Awards & highlights

Study Summary

This trial seeks to develop and test a low-cost, portable scope to diagnose head and neck cancers in areas with limited resources, comparing it to the standard of care.

Eligible Conditions

Oral Cancers
Head and Neck Cancers

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 15 minutes

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 15 minutes

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 15 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Number of providers who who reported the FNS is easy to use

Secondary outcome measures

Number of patients who experienced an adverse event following the use of the flexible scope

Number of patients who reported perceived pain following use of the flexible scope

Rate of image quality of flexible scope

+1 more

Trial Design

3Treatment groups

Active Control

Group I: Patients evaluated using flexible nasopharyngoscope prototype deviceActive Control1 Intervention

Group II: Patients evaluated using standard of care nasopharyngoscopeActive Control1 Intervention

Group III: Providers using flexible nasopharyngoscope prototype deviceActive Control1 Intervention

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Duke UniversityLead Sponsor

2,377 Previous Clinical Trials

3,427,119 Total Patients Enrolled

National Institute of Dental and Craniofacial Research (NIDCR)NIH

300 Previous Clinical Trials

848,294 Total Patients Enrolled

2 Trials studying Oral Cancers

55 Patients Enrolled for Oral Cancers

Walter Lee, MDPrincipal InvestigatorDuke Health

1 Previous Clinical Trials

50 Total Patients Enrolled

Media Library

Flexible Nasopharyngoscope (N/A) Clinical Trial Eligibility Overview. Trial Name: NCT04905134 — N/A

Oral Cancers Research Study Groups: Patients evaluated using flexible nasopharyngoscope prototype device, Patients evaluated using standard of care nasopharyngoscope, Providers using flexible nasopharyngoscope prototype device

Oral Cancers Clinical Trial 2023: Flexible Nasopharyngoscope Highlights & Side Effects. Trial Name: NCT04905134 — N/A

Flexible Nasopharyngoscope (N/A) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04905134 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any slots still available for this research initiative?

"This study, first posted on the 8th of August 2023 and last updated at the 10th of July 2023 is not actively recruiting patients. Nevertheless, 558 studies are currently searching for participants across multiple criteria."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Low-Cost, Portable Flexible Nasopharyngoscope in Head & Neck Cancers in Low Resource Settings - Optimization Phase

2023. "Low-Cost, Portable Flexible Nasopharyngoscope in Head & Neck Cancers in Low Resource Settings - Optimization Phase". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04905134.